TP53 Pro47Ser and Arg72Pro polymorphisms and colorectal cancer predisposition in an ethnic Kashmiri population

Genetics and Molecular Research

Volumn 9, Issue 2, 2010, Pages 651-660

  Sameer, A S ^a,b   Shah, Z A ^a   Syeed, N ^a   Banday, M Z ^c   Bashir, S M ^a   Bhat, B A ^d   Siddiqi, M A ^a  

^a Molecular Medicine   (India)

^b SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

^c UNIVERSITY OF KASHMIR   (India)

^d Sher e Kashmir University of Agricultural Science and Technology   (India)

Author keywords

Colorectal cancer; Kashmir; Polymorphism; Restriction digestion; RFLP; TP53

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MUTANT; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DEMOGRAPHY; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIA; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77954452201     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/vol9-2gmr751     Document Type: Article

References (40)

1. Beckman G, Birgander R, Sjalander A, Saha N, et al. (1994). Is p53 polymorphism maintained by natural selection? Hum. Hered. 44: 266-270.
2. Bojesen SE and Nordestgaard BG (2008). The common germline Arg72Pro polymorphism of p53 and increased longevity in humans. Cell Cycle 7: 158-163.
3. Boyle P and Leon ME (2002). Epidemiology of colorectal cancer. Br. Med. Bull. 64: 1-25.
4. Costa S, Pinto D, Pereira D, Rodrigues H, et al. (2008). Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer. BMC Cancer 8: 32.
5. Devesa SS and Chow WH (1993). Variation in colorectal cancer incidence in the United States by subsite of origin. Cancer 71: 3819-3826.
6. Dumont P, Leu JI, Della Pietra AC, George DL, et al. (2003). The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat. Genet. 33: 357-365.
7. Felley-Bosco E, Weston A, Cawley HM, Bennett WP, et al. (1993). Functional studies of a germ-line polymorphism at codon 47 within the p53 gene. Am. J. Hum. Genet. 53: 752-759.
8. Gapstur SM, Potter JD and Folsom AR (1994). Alcohol consumption and colon and rectal cancer in postmenopausal women. Int. J. Epidemiol. 23: 50-57.
9. Gemignani F, Moreno V, Landi S, Moullan N, et al. (2004). A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA. Oncogene 23: 1954-1956.
10. Hamajima N, Matsuo K, Suzuki T, Nakamura T, et al. (2002). No associations of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro polymorphisms with the risk of digestive tract cancers in Japanese. Cancer Lett. 181: 81-85.
11. Hiyama T, Tanaka S, Kitadai Y, Ito M, et al. (2002). p53 Codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis. Int. J. Cancer 100: 304-308.
12. Iacopetta B (2003). TP53 mutation in colorectal cancer. Hum. Mutat. 21: 271-276.
13. Ignaszak-Szczepaniak M, Horst-Sikorska W, Sawicka J, Kaczmarek M, et al. (2006). The TP53 codon 72 polymorphism and predisposition to adrenocortical cancer in Polish patients. Oncol. Rep. 16: 65-71.
14. Irarrazabal CE, Rojas C, Aracena R, Marquez C, et al. (2003). Chilean pilot study on the risk of lung cancer associated with codon 72 polymorphism in the gene of protein p53. Toxicol. Lett. 144: 69-76.
15. Katkoori VR, Jia X, Shanmugam C, Wan W, et al. (2009). Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma. Clin. Cancer Res. 15: 2406-2416.
16. Lee JM, Lee YC, Yang SY, Shi WL, et al. (2000). Genetic polymorphisms of p53 and GSTP1, but not NAT2, are associated with susceptibility to squamous-cell carcinoma of the esophagus. Int. J. Cancer 89: 458-464.
17. Leu JI, Dumont P, Hafey M, Murphy ME, et al. (2004). Mitochondrial p53 activates Bak and causes disruption of a Bak- Mcl1 complex. Nat. Cell Biol. 6: 443-450.
18. Li X, Dumont P, Della PA, Shetler C, et al. (2005). The codon 47 polymorphism in p53 is functionally significant. J. Biol. Chem. 280: 24245-24251.
19. Lung FW, Lee TM, Shu BC and Chang FH (2004). p53 codon 72 polymorphism and susceptibility malignancy of colorectal cancer in Taiwan. J. Cancer Res. Clin. Oncol. 130: 728-732.
20. Marin MC, Jost CA, Brooks LA, Irwin MS, et al. (2000). A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat. Genet. 25: 47-54.
21. Mir MM, Dar NA, Gochhait S, Zargar SA, et al. (2005). p53 mutation profile of squamous cell carcinomas of the esophagus in Kashmir (India): a high-incidence area. Int. J. Cancer 116: 62-68.
22. Murphy ME (2006). Polymorphic variants in the p53 pathway. Cell Death Differ. 13: 916-920.
23. Murtaza I, Mushtaq D, Margoob MA, Dutt A, et al. (2006). A study on p53 gene alterations in esophageal squamous cell carcinoma and their correlation to common dietary risk factors among population of the Kashmir valley. World J. Gastroenterol. 12: 4033-4037.
24. Perez LO, Abba MC, Dulout FN and Golijow CD (2006). Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, Argentina. World J. Gastroenterol. 12: 1426-1429.
25. Pietsch EC, Humbey O and Murphy ME (2006). Polymorphisms in the p53 pathway. Oncogene 25: 1602-1611.
26. Pinto GR, Yoshioka FK, Silva RL, Clara CA, et al. (2008). Prognostic value of TP53 Pro47Ser and Arg72Pro single nucleotide polymorphisms and the susceptibility to gliomas in individuals from Southeast Brazil. Genet. Mol. Res. 7: 207-216.
27. Sameer AS, Ul Rehman S, Pandith AA, Syeed N, et al. (2009). Molecular gate keepers succumb to gene aberrations in colorectal cancer in Kashmiri population, revealing a high incidence area. Saudi J. Gastroenterol. 15: 244-252.
28. Sayhan N, Yazici H, Budak M, Bitisik O, et al. (2001). P53 codon 72 genotypes in colon cancer. Association with human papillomavirus infection. Res. Commun. Mol. Pathol. Pharmacol. 109: 25-34.
29. Schneider-Stock R, Boltze C, Peters B, Szibor R, et al. (2004). Selective loss of codon 72 proline p53 and frequent mutational inactivation of the retained arginine allele in colorectal cancer. Neoplasia 6: 529-535.
30. Shah A and Jan GM (1990). Pattern of cancer at Srinagar (Kashmir). Indian J. Pathol. Microbiol. 33: 118-123.
31. Siddiqi M, Kumar R, Fazili Z, Spiegelhalder B, et al. (1992). Increased exposure to dietary amines and nitrate in a population at high risk of oesophageal and gastric cancer in Kashmir (India). Carcinogenesis 13: 1331-1335.
32. Sjalander A, Birgander R, Athlin L, Stenling R, et al. (1995). P53 germ line haplotypes associated with increased risk for colorectal cancer. Carcinogenesis 16: 1461-1464.
33. Sjalander A, Birgander R, Hallmans G, Cajander S, et al. (1996). p53 polymorphisms and haplotypes in breast cancer. Carcinogenesis 17: 1313-1316.
34. Soussi T and May P (1996). Structural aspects of the p53 protein in relation to gene evolution: a second look. J. Mol. Biol. 260: 623-637.
35. Thomas M, Kalita A, Labrecque S, Pim D, et al. (1999). Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol. Cell Biol. 19: 1092-1100.
36. Toyama T, Zhang Z, Nishio M, Hamaguchi M, et al. (2007). Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients. Breast Cancer Res. 9: R34.
37. Whibley C, Pharoah PD and Hollstein M (2009). p53 polymorphisms: cancer implications. Nat. Rev. Cancer 9: 95-107.
38. Zehbe I, Voglino G, Delius H, Wilander E, et al. (1998). Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet 352: 1441-1442.
39. Zhu ZZ, Wang AZ, Jia HR, Jin XX, et al. (2007). Association of the TP53 codon 72 polymorphism with colorectal cancer in a Chinese population. Jpn. J. Clin. Oncol. 37: 385-390.
40. Zhu ZZ, Liu B, Wang AZ, Jia HR, et al. (2008). Association of p53 codon 72 polymorphism with liver metastases of colorectal cancers positive for p53 overexpression. J. Zhejiang. Univ. Sci. B 9: 847-852.